Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor.

So-Jung Gwak Lihua Che Yeomin Yun Minhyung Lee Yoon Ha

Published in: Yonsei medical journal (2020)

This study suggests that combination therapy using bevacizumab with the pEpo-NI2-SV-TK therapeutic gene could be useful for increasing its therapeutic benefits for intramedullary spinal cord tumors.

Keyphrases

combination therapy
spinal cord
spinal cord injury
copy number
neuropathic pain
genome wide
metastatic colorectal cancer
genome wide analysis